Effect of piceatannol-rich passion fruit seed extract on human glyoxalase I-mediated cancer cell growth.

Yamamoto, Takayuki; Sato, Akira; Takai, Yusuke; Yoshimori, Atsushi; Umehara, Masahiro; Ogino, Yoko; Inada, Mana; Shimada, Nami; Nishida, Aya; Ichida, Risa; Takasawa, Ryoko; Maruki-Uchida, Hiroko; Mori, Sadao; Sai, Masahiko; Morita, Minoru; Tanuma, Sei-Ichi

Yamamoto, Takayuki; Sato, Akira; Takai, Yusuke; Yoshimori, Atsushi; Umehara, Masahiro; Ogino, Yoko; Inada, Mana; Shimada, Nami; Nishida, Aya; Ichida, Risa; Takasawa, Ryoko; Maruki-Uchida, Hiroko; Mori, Sadao; Sai, Masahiko; Morita, Minoru; Tanuma, Sei-Ichi.

Yamamoto T; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Sato A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Takai Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Yoshimori A; Institute for Theoretical Medicine Inc., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-0012, Japan.
Umehara M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Ogino Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Inada M; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Shimada N; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Nishida A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Ichida R; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Takasawa R; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Maruki-Uchida H; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Mori S; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Sai M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Morita M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan.
Tanuma SI; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.

Biochem Biophys Rep ; 20: 100684, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31517069

Palabras clave

Anticancer; GLO I, glyoxalase I; Glyoxalase I; HPLC, high-performance liquid chromatography; IL-6, interleukin 6; MAPK, mitogen-activated protein kinase; MG, methylglyoxal; PFSE, Passion fruit seed extract; PI3K, phosphoinositide 3-kinase; Passion fruit seed extract; Piceatannol; STAT3, signal transducers and activators of transcription 3; TCA, tricarboxylic acid; mTOR, mammalian target of rapamycin

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2019 Tipo del documento: Article